Vasculitis & polymyalgia rheumatica

Macrovascular damage in polymyalgia rheumatica: integrated vascular phenotyping in the POLYMYACARD cohort

Arthritis Res TherPublished Cross-sectional study

Authors' conclusion

Patients with PMR exhibited increased aortic stiffness and elevated carotid pulsatility and resistance in the ECA compared with controls, independent of traditional CV risk factors.

Study context

Population
Patients with PMR (POLYMYACARD cohort) and controls26 PMR also had GSUS/CDUS
Exposure
PMR vs controls
  • PMRn = 72
Outcome
Macrovascular damage: aortic stiffness (cfPWV) and carotid GSUS/CDUS markers
Methodological detailscontrolled, multivariable linear regression, propensity score matching
  • Controlled
  • Multivariable linear regression
  • Propensity score matching

Main finding

As reported in the abstract

Vascular markers, PMR vs controls (after multivariable linear regression (MLR) and PSM)
  • PMR vs Controls: padj=0.012
  • PMR vs Controls: padj=0.020
  • PMR vs Controls: padj=0.027

Observational data: associations, not effects.

Further findings

Subclinical arteriosclerosis prevalence (PSM)

adjusted p = 0.028

  • Subclinical arteriosclerosis prevalence (propensity score matching (PSM)): 13/16 vs. 7/16

Plaque area, elevated CRP vs not (PMR)

Plaque area greater with elevated CRP: 0.41 (0.13-1.07) vs. 0.05 (0.00-0.31); p = 0.016

Correlations with age

Carotid-femoral pulse wave velocity (cfPWV), p < 0.001
r = 0.588
Carotid intima-media thickness (cIMT), p = 0.004
r = 0.542
Plaques, p < 0.001
r = 0.662

Correlations with mean arterial pressure

cfPWV, p = 0.038
ρ = 0.247
cIMT, p = 0.020
r = 0.515
Plaques, p = 0.006
r = 0.596

Original publication

Macrovascular damage in polymyalgia rheumatica: integrated vascular phenotyping in the POLYMYACARD cohort. Arthritis Res Ther. Published 15 September 2026. doi:10.1186/s13075-026-03886-8

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.